Read the latest ideas, insights and observations on the Australian Medicinal Cannabis Industry from the team at Applied Cannabis Research

Medicinal Cannabis and Wasting Syndrome: What Can It Do?

Medicinal Cannabis and Wasting Syndrome: What Can It Do?   Cachexia is a condition, also known as ‘wasting syndrome’, characterised by loss of body mass associated with an underlying medical condition such as HIV, tuberculosis, autoimmune conditions, cancer and cancer treatments – to mention a few.   Patients suffering from cachexia, from any underlying condition,...
Read More

Medical Cannabis and Driving

Australian Law Needs to Catch Up With Medicinal Cannabis Usage By Jessica Kindynis As Australian medical cannabis patient numbers rapidly grow, there is a great need for updated and cohesive laws regarding driving and cannabis. With medical and adult-use increasing in prevalence around the globe, researchers are racing to assess the impact of cannabinoids on...
Read More

Untangling GMP in Australia’s Medical Cannabis Landscape 

Untangling GMP in Australia’s Medical Cannabis Landscape There are plenty of acronyms to wrap your head around in the cannabis world and GMP or Good Manufacturing Practice is one that is at the forefront of the industry. Around the globe there’s been a shift towards extract-based products over raw flower for medical cannabis consumption, promoting...
Read More

The importance of dosing studies

The importance of dosing studies   The emergence of a federally regulated pharmaceutical framework for medicinal cannabis in Australia has resulted in substantial opportunities for medicinal cannabis companies to undertake research and development (R&D) here.    Within the realms of novel drug development, comprehension and accuracy regarding dosage and titration regimens have extreme significance to the...
Read More

News Release: Applied Cannabis Research launches study of Cannabinoids and PTSD

News Release: Applied Cannabis Research launches study of Cannabinoids and PTSD Applied Cannabis Research is pleased to announce it has received ethics approval for a study into the benefits of cannabinoids and post-traumatic stress disorder (PTSD). The study will commence in May of 2019 and will study up to 300 PTSD patients who have been...
Read More

Cannabis Clinics Facilitate Enhanced Trial Recruitment

Using Cannabis Clinics for Medical Cannabis Trial Recruitment The age-old problem and one of the biggest hurdles in clinical trials is recruitment. It’s the ultimate rate limiting step which can significantly impact clinical development timelines. As any sponsor of a clinical trial can attest to the most demanding stages of any clinical trial is the...
Read More

Why Australia should be your next clinical trial destination

Why Australia is the best location in the world for medicinal cannabis trials Australia is emerging as a leading destination for pharmaceutical companies to conduct research into medicinal cannabis.  Companies like GW Pharmaceuticals, Zynerba, Tilray, Botanix, Zelda Therapeutics and others have all made announcements in recent years about medicinal cannabis research programs here. The reasons...
Read More

Leave us your info

and we will get back to you.